-+ 0.00%
-+ 0.00%
-+ 0.00%

CADRENAL THERAPEUTICS INC - TO ADVANCE DIRECTLY TO PHASE 3 STUDY OF CAD-1005 IN HIT

Reuters·04/30/2026 12:30:01

Please log in to view news